Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
Subscribe To Our Newsletter & Stay Updated
